Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

After evaluating the existing literature and grading recommendations using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) method, experts from the Bone Working...

Online resource for healthcare professionals, providing information, news & support relating to multiple...

Online resource for healthcare professionals, providing information, news & support relating to multiple...

During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub hosted its first Satellite Symposium: Should ‘cure’ be the...

Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary recommendations issued by the National Comprehensive Cancer Network (NCCN) COVID-19...

On August 30, 2021, it was announced that the U.S Food and Drug Administration (FDA) has cleared an Investigational New Drug application for P-BCMA-ALLO1...

Whilst durable responses are often observed for CD19-directed CAR T-cell therapies in acute lymphoblastic leukemia, it has proven challenging to achieve durable responses to...

Patients with hematologic malignancies (HMs) may have intensified immune dysregulation resulting from both therapeutic agents and malignancy burden. As a result, these patients are...

The potential of belantamab mafodotin (belamaf) in the relapsed or refractory (R/R) multiple myeloma (MM) setting was highlighted in 2019, when the pivotal DREAMM-2...